EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
2.7.11.18 | additional information | treatment with pentoxifylline attenuates activation of MLCK likely through its ability to decrease local tumor necrosis factor-alpha synthesis and nucleat factor kappaB activation after burn | Mus musculus | |
2.7.11.18 | tumor necrosis factor-alpha | - |
Mus musculus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.7.11.18 | Mus musculus | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.7.11.18 | small intestine | - |
Mus musculus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.11.18 | ATP + myosin light chain | - |
Mus musculus | ADP + myosin light chain phosphate | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.7.11.18 | MLCK | - |
Mus musculus |
2.7.11.18 | myosin light chain kinase | - |
Mus musculus |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
2.7.11.18 | ATP | - |
Mus musculus |
EC Number | Organism | Comment | Expression |
---|---|---|---|
2.7.11.18 | Mus musculus | severe burn injury increases intestinal MLCK protein levels 3.6fold after 2h in animals resuscitated with normal saline | up |